亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Weekly Journal Scan: A reassuring answer to questions about statin therapy and diabetes

医学 糖尿病 他汀类 安慰剂 内科学 不利影响 随机对照试验 养生 糖化血红蛋白 2型糖尿病 物理疗法 内分泌学 替代医学 病理
作者
Daniela Pedicino,Massimo Volpe
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:45 (41): 4449-4450
标识
DOI:10.1093/eurheartj/ehae486
摘要

Key Points• In this meta-analysis of individual participant data from 23 double-blind, randomized controlled trials (RCTs) participating in the Cholesterol Treatment Trialists' (CTT) Collaboration, the authors sought to investigate the effects of statin therapy allocation on new-onset diabetes and on worsening glycaemia in patients with diabetes.• Eligibility criteria for RCTs were as follows: (i) no protocol-mandated differences between treatment groups other than those created by allocation to receive statin and its comparator (placebo or a statin with different intensity); (ii) at least 1000 patients enrolled; and (iii) a mean scheduled follow-up of at least 2 years.• Baseline diabetes was defined as a recorded history of diabetes or diabetes-related adverse event, use of glucose-lowering medications, fasting plasma glucose concentration ≥7 mmol/L, random plasma glucose ≥11.1 mmol/L, or glycated haemoglobin (HbA1c) value ≥6.5% on or before the date of participant assignment to a treatment group.New-onset diabetes was defined with the above-mentioned characteristics recorded after participant assignment to a treatment group.Worsening glycaemia was defined as any adverse event relating to ketosis or glucose control, HbA1c increase from baseline of ≥0.5%, or escalation of glucose-lowering medications after participant assignment to a treatment group.• Of the included RCTs, 19 compared any statin regimen with placebo, with 123 940 participants, a median follow-up of 4 years, and 25 701 subjects (21%) with a history of diabetes or meeting the prespecified definition of baseline diabetes.In the analysis of the RCTs comparing low-or moderate-intensity statin vs. placebo (n = 14), the allocation to statin treatment resulted in a 10% increase in new-onset diabetes [2420 of 39 179 participants in the statin group vs. 2214 of 39 266 participants assigned to placebo; relative risk (RR), 1.10; 95% confidence interval (CI), 1.04-1.16],corresponding to an incidence of 1.3% per year compared to 1.2% in the placebo group, with a mean absolute excess of 0.12% during each year of treatment.Those treated with a high-intensity statin (two RCTs) had a larger, 36% proportional increase in newonset diabetes (1221 of 9935 participants in the statin group vs. 905 of 9859 participants assigned to placebo; RR, 1.36; 95% CI, 1.25-1.48),with rates of 4.8% vs. 3.5% per year and an absolute annual excess of 1.27%.Of note, in the high-intensity statin trials, HbA1c and glucose levels were measured in 72% and 49% of participants without diabetes at baseline vs. 3% and 37% of those in the low-or moderate-intensity statin trials.• In the 4 RCTs comparing more vs.less intensive statin therapy (30 724 participants, 17% with diabetes, median follow-up of 5 years), highintensity regimens resulted in a 10% increase in newly diagnosed diabetes (RR, 1.10; 95% CI, 1.02-1.18).For a given level of statin intensity, the results were consistent among participant subgroups (e.g. by age, sex, race, and body mass index) and did not vary over time.Among patients without diabetes at baseline, the mean increase in glucose concentration compared with placebo was 0.04 mmol/L for both low-or moderateintensity and high-intensity statin therapy, and the increases in HbA1c values were 0.06% for low-or moderate-intensity and 0.08% for highintensity statin therapy.Up to 62% of new-onset diabetes occurred among participants in the highest quartiles of glycaemia distribution.• In those with pre-existing diabetes, low-or moderate-intensity statins resulted in a 10% relative increased risk of worsening glycaemia compared with placebo (RR, 1.10; 95% CI, 1.06-1.14;absolute annual excess 1.49%), and high-intensity statins resulted in a 24% relative worsening of glycaemia compared with placebo (RR, 1.24; 95% CI, 1.06-1.44;absolute annual excess 3.02%).The mean increase in glucose concentration compared with placebo was 0.12 mmol/L for low-or moderate-intensity statin therapy and 0.22 mmol/L for high-intensity statin therapy, with a corresponding increase in HbA1c values of 0.09% for low-or moderate-intensity and 0.24% for high-intensity statin therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
半只熊完成签到 ,获得积分10
2秒前
3秒前
6秒前
一只熊完成签到 ,获得积分10
7秒前
13秒前
科研通AI5应助Lojong采纳,获得10
15秒前
刘子超发布了新的文献求助10
17秒前
无花果应助奔跑的小鹰采纳,获得30
21秒前
小助应助奔跑的小鹰采纳,获得10
21秒前
25秒前
科研通AI5应助斯文雁易采纳,获得10
26秒前
科研通AI5应助Jiang采纳,获得10
33秒前
科研通AI5应助斯文雁易采纳,获得10
39秒前
火星上的菲鹰应助Zhou采纳,获得10
40秒前
活力妙芙完成签到 ,获得积分10
47秒前
chen完成签到 ,获得积分10
48秒前
1分钟前
didi123发布了新的文献求助10
1分钟前
科研通AI5应助斯文雁易采纳,获得10
1分钟前
1分钟前
稻草人发布了新的文献求助10
1分钟前
科研通AI5应助斯文雁易采纳,获得10
1分钟前
酷酷薯片完成签到,获得积分10
1分钟前
Jasper应助斯文雁易采纳,获得10
1分钟前
汉堡包应助佳佳采纳,获得10
1分钟前
1分钟前
思源应助didi123采纳,获得10
1分钟前
Lojong发布了新的文献求助10
1分钟前
1分钟前
1分钟前
2分钟前
佳佳发布了新的文献求助10
2分钟前
佳佳完成签到,获得积分10
2分钟前
Aaron完成签到,获得积分10
2分钟前
2分钟前
徐小越关注了科研通微信公众号
2分钟前
2分钟前
科研通AI5应助蓝莓丢了霉采纳,获得10
3分钟前
非想非非想应助明亮不乐采纳,获得10
3分钟前
徐小越发布了新的文献求助10
3分钟前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Les Mantodea de Guyane Insecta, Polyneoptera 1000
Conference Record, IAS Annual Meeting 1977 820
England and the Discovery of America, 1481-1620 600
Fault identification method of electrical automation distribution equipment in distribution networks based on neural network 560
Teaching language in context (Third edition) by Derewianka, Beverly; Jones, Pauline 550
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3580358
求助须知:如何正确求助?哪些是违规求助? 3149890
关于积分的说明 9479310
捐赠科研通 2851398
什么是DOI,文献DOI怎么找? 1567783
邀请新用户注册赠送积分活动 734253
科研通“疑难数据库(出版商)”最低求助积分说明 720565